Enhancing the QUAlity and Transparency Of health Research
Use your browser's Back button to return to your search results
|Reporting guideline provided for?
(i.e. exactly what the authors state in the paper)
|Reporting of trials and trial protocols that undergo important modifications in response to extenuating circumstances.
CONSERVE-CONSORT & CONSERVE-SPIRIT Checklists (Word)
|Full bibliographic reference||Orkin AM, Gill PJ, Ghersi D, Campbell L, Sugarman J, Emsley R, Steg PG, Weijer C, Simes J, Rombey T, Williams HC, Wittes J, Moher D, Richards DP, Kasamon Y, Getz K, Hopewell S, Dickersin K, Wu T, Ayala AP, Schulz KF, Calleja S, Boutron I, Ross JS, Golub RM, Khan KM, Mulrow C, Siegfried N, Heber J, Lee N, Kearney PR, Wanyenze RK, Hróbjartsson A, Williams R, Bhandari N, Jüni P, Chan AW; CONSERVE Group. Guidelines for Reporting Trial Protocols and Completed Trials Modified Due to the COVID-19 Pandemic and Other Extenuating Circumstances: The CONSERVE 2021 Statement. JAMA. 2021.|
(full-text if available)
|The full-text of the CONSERVE 2021 Statement is freely available.
The authors have developed an implementation tool and two reporting checklists for CONSERVE which are included as a supplement to the journal article.
|Reporting guideline acronym||CONSERVE|
|Study design||Clinical trials, Experimental studies, Study protocols|
|Applies to the whole report or to individual sections of the report?||Whole report|
|Additional information||The CONSERVE 2021 Statement is an extension to both the CONSORT and SPIRIT Statements.|
|Record last updated on||October 1, 2021|
Some reporting guidelines are also available in languages other than English. Find out more in our Translations section.